Efficacy of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease

被引：0

作者：

Hauser, Robert ^{[2
]}

Dzyngel, Bruce ^{[1
]}

Bilbault, Thierry ^{[1
]}

Shill, Holly

Argo, Albert ^{[1
]}

机构：

[1] Cynapsus Therapeut Inc, Toronto, ON, Canada

[2] Movement Disorders Ctr, Tampa, FL USA

来源：

NEUROLOGY | 2016年 / 86卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P2.335

引用

下载

页数：2

共 50 条

[31] Safety and tolerability of apomorphine sublingual film and subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's disease
Rascol, O.
Poewe, W.
Stocchi, F.
Chaudhuri, R.
Kassube, J.
Manzanares, L. Lopez
Leta, V.
Zhang, I.
Bowling, A.
Wu, S.
Pappert, E.
MOVEMENT DISORDERS, 2022, 37 : S348 - S348
[32] Sublingual Apomorphine Manages Parkinson Disease Off Episodes
Slomski, Anita
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (08): : 701 - 701
[33] Buccal mucosal irritation studies of sublingual apomorphine film (APL-130277) in Syrian golden hamsters
Bilbault, Thierry
Taylor, Simon
Walker, Robin
Grundy, Starr L.
Pappert, Eric J.
Agro, Albert
THERAPEUTIC DELIVERY, 2016, 7 (09) : 611 - 618
[34] Disease severity is not predictive of the dose required for apomorphine sublingual film (APL-130277) to convert a patient with Parkinson's disease (PD) from OFF to fully ON: preliminary results from a phase iii study
Fernandez, H.
Isaacson, S.
Espay, A.
Pahwa, R.
Truong, D.
Pappert, E.
Gardzinski, P.
Dzyngel, B.
Agro, A.
Hauser, R.
MOVEMENT DISORDERS, 2017, 32
[35] Oral sublingual apomorphine film (APL-130277) produces no buccal mucosal irritation: results of a toxicological study
Pappert, E.
Dzyngel, B.
Bilbault, T.
Agro, A.
EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 658 - 658
[36] A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson's disease 'OFF' episodes
Caughman, Christopher Y.
Factor, Stewart
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (02) : 169 - 177
[37] Budget Impact of Apomorphine Sublingual Film for On-Demand Treatment of Patients With Parkinson's Disease and "OFF" Episodes
Thach, A.
Kirson, N.
Zichlin, M.
Dieye, I.
Pappert, E.
Williams, G.
MOVEMENT DISORDERS, 2020, 35 : S427 - S427
[38] Apomorphine Sublingual Film for On-Demand Treatment of "OFF" Episodes in Patients With Parkinson's Disease: Impact on Dyskinesia
Klos, K.
Hui, J.
Robottom, B.
Bhargava, P.
Navia, B.
MOVEMENT DISORDERS, 2020, 35 : S404 - S404
[39] EXPOSURE-RESPONSE EFFICACY MODEL OF APOMORPHINE SUBLINGUAL FILM FOR THE ON-DEMAND TREATMENT OF "OFF" EPISODES IN PATIENTS WITH PARKINSON'S DISEASE
Agbo, F.
Chiu, Y. -Y.
Chapel, S.
Navia, B.
PARKINSONISM & RELATED DISORDERS, 2020, 79 : E85 - E86
[40] Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's Disease: Impact on Dyskinesia
Klos, K.
Hui, J.
Zhang, I.
Pappert, E.
Navia, B.
MOVEMENT DISORDERS, 2021, 36 : S180 - S180

← 1 2 3 4 5 →